Seminars in Oncology
Volume 33, Issue 6 , Pages 681-687, December 2006

Selecting Endocrine Therapy for Breast Cancer: What Role Does HER-2/neu Status Play?

  • Tatiana M. Prowell

      Affiliations

    • Breast Cancer Research Program, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD.
    • ,
  • Deborah K. Armstrong

      Affiliations

    • Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD.
    • Corresponding Author InformationAddress correspondence to Deborah K. Armstrong, MD, Associate Professor, Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, CRB-I, Room 190, 1650 Orleans St, Baltimore, MD 21231.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 T.M.P.’s work is supported by an American Society of Clinical Oncology Young Investigator Award and a Pearl M. Stetler Research Fund Award.

PII: S0093-7754(06)00327-7

doi:10.1053/j.seminoncol.2006.08.016

Seminars in Oncology
Volume 33, Issue 6 , Pages 681-687, December 2006

Article Tools